J&J beats fourth-quarter earnings expectations, will release Covid vaccine data ‘soon’

FAN Editor

Johnson & Johnson Coronavirus vaccine illustration

Dado Ruvic | Reuters

Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that beat Wall Street’s expectations.

Here’s how J&J did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

  • Adjusted EPS: $1.86 per share versus $1.82 expected.
  • Revenue: $22.48 billion versus $21.67 billion expected.

“I’m incredibly proud of our Johnson & Johnson teams around the world for going above and beyond to meet stakeholder needs,” J&J CEO Alex Gorsky said in a press release. “We continue to progress our COVID-19 vaccine candidate and look forward to sharing details from our Phase 3 study soon.”

This is a developing story. Please check back for updates.

Free America Network Articles

Leave a Reply

Next Post

Alabama tornado kills at least one, injures dozens

One person is dead after a tornado tore through an Alabama city north of Birmingham Monday night, leaving the area with crumpled buildings and downed trees. Fultondale Fire Chief Justin McKenzie confirmed the death to CBS News, adding that 17 others were brought to hospitals and 11 more were treated […]